Cite

HARVARD Citation

    Xu, X. et al. (2020). Reprogramming Tumor Associated Macrophages toward M1 Phenotypes with Nanomedicine for Anticancer Immunotherapy. Advanced therapeutics. 3 (5), p. n/a. [Online]. 
  
Back to record